Found 91 matching trials
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma PHASE1 The goal of the Phase I part of this clinical research study is to find the...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET PHASE2 The purpose of the study is to evaluate the efficacy and tolerability of th...
Show More Location
Vienna General Hospital
Learn More & Join Trial
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. PHASE1 A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblasto...
Show More Status
Active Not Recruiting
Location
Col Uni Med Center New York Presby
Learn More & Join Trial
Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma PHASE1 The early clinical development paradigm for chemotherapeutic agents has sig...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
LAM561 With RT and TMZ for Adults With Glioblastoma PHASE2 The proposed Phase IIB/III randomized, double-blind, placebo-controlled tri...
Show More Status
Active Not Recruiting
Location
Institut Cancerologie de L'Ouest (ICO)
Learn More & Join Trial
Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma PHASE1 This is a prospective, single-center, open-label, 3+3 dose escalation Phase...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas EARLY_PHASE1 The outcome for children with high-grade gliomas and diffuse intrinsic brai...
Show More Location
Ann & Robert H. Lurie Children's Hospital of Chicago
Learn More & Join Trial
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. EARLY_PHASE1 Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Show More Location
Biogenea Pharmaceuticals Ltd
Learn More & Join Trial
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma PHASE1 The purpose of this study is to establish the recommended phase 2 dose of e...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma PHASE1 This clinical trial is a rollover study designed to provide continued acces...
Show More Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Learn More & Join Trial